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Abstract
Cytotoxic anti-thyroid microsomal autoantibodies are highly prevalent in sera of patients with
Graves’ disease, but in Graves’ disease thyroid tissues rarely show destructive changes. We pos-
tulated that this might be due to membrane-associated complement regulatory proteins which pro-
tect target cells from injury by complement activation. We, therefore, investigated the expression
of membrane attack complex inhibitory factor (MACIF) and decay accelerating factor (DAF) in
the thyroid tissues from patients with Graves’ disease, Hashimoto’s thyroiditis, thyroid adeno-
carcinoma and normal human thyroid tissues. We found a high level of expression of MACIF
and DAF in Graves’ thyroid tissues. Using the membrane immunofluorescence and cell-ELISA
techniques, we also investigated the factors which enhanced the MACIF and DAF expression in
cultured thyroid cells. Thyroid stimulating hormone, phorbol 12, 13-dibutyrate and thyroid stim-
ulating autoantibody enhanced the MACIF and DAF expression. These findings suggest that the
membrane complement regulatory proteins increase in response to the thyroid stimulating factors
such as thyroid stimulating autoantibody in Graves’ disease and that this increase then protects the
cells from damage due to complement activation by thyroid autoantibodies.
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